Mobile Biosensor for Measuring Vital Signs in Healthcare & Home Settings

Status Recruiting

Clinical Trial Summary

This study will record vital signs (heart rate and blood oxygen levels) using a new cell phone integrated biosensor and compare it to routine measurements carried out in the clinics and hospital at UCSD. Cell phones will be given to a selected group of subjects for use at home and data collected.

Clinical Trial Description

Maxim Vital Sign study is a 2 part, investigator initiated observational study with Maxim Integrated aimed to compare vital sign readings using 2 prototype versions of new cell phone based mobile biosensors with standard of care (SOC). Adult subjects will be recruited from UCSD outpatient clinics, AVRC clinic, emergency department (ED), and hospitals. Vital signs will be measured using cell phone based mobile biosensors and SOC. For Phase 1, up to 800 subjects will be recruited (700 adults and up to 100 adolescents). 250 subjects (200 adults and up to 50 adolescents) will participate in phase 1a and 550 subjects (500 adults and up to 50 adolescents) will participate in phase 1b. An additional group of 30 adult subjects will be recruited from outpatient clinics for participation in phase 2. Phase 1a: Two identical copies of the device will be tested during the first part of phase 1 with a total of 125 subjects (100 adults and up to 25 adolescents). Each prototype version will be tested on up to 125 subjects (100 adults and 25 adolescents) and compared to readings obtained by Welch-Allyn Spot Vital Signs monitor. Data will be obtained on the usability and accuracy of the measurements with each initial prototype. Measurement particularly of SpO2 depends on accurate finger position. Current SpO2 monitors encase the finger and immobilize it in order to obtain an accurate measurement. Maxim Integrated, in collaboration with DD Studios, Carlsbad CA, and Specialists in Global Health, Encinitas CA, have developed prototypes, which will be tested to inform design flaws in future prototypes. Phase 1b: Based on the results from phase 1a, one of the prototypes will be selected for further testing (the one with the least within-instrument variation). During Phase 1b, vital sign readings will be collected with the selected Maxim biosensor prototype and one of the Welch-Allyn Spot Vital Signs monitor simultaneously. The subjects will be recruited from both outpatient and hospital settings for accuracy and usability. A total of 550 subjects (500 adults and 50 adolescents) will be recruited for this part of phase 1. ;

Study Design

Related Conditions & MeSH terms

Pulse Oximetry

Clinical Trial Details

NCT number	NCT04233827
Study type	Observational
Source	University of California, San Diego
Contact	Sara H Browne, MD MPH
Phone	619 543 8080
Email	shbrowne@health.ucsd.edu
Status	Recruiting
Phase
Start date	October 20, 2016
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02846974` - Calibration and Validation of High Quality Low-Cost 3D Printed Pulse Oximeter
Completed	`NCT03383757` - U-TruSignal SpO2 Testing in Neonates	N/A
Completed	`NCT02987985` - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy	Phase 3
Completed	`NCT05185427` - Pulse Oximetry and Skin Pigmentation - Peds
Terminated	`NCT03843489` - SpO2 Accuracy In Vivo Testing for Neonates & Infants	N/A
Recruiting	`NCT06298422` - Oxygen Saturations Across Tones of Skin
Completed	`NCT01472133` - Validation of Respiration Rate Algorithms	N/A
Completed	`NCT01613222` - SpO2 System Accuracy Testing With Different Sensors	N/A
Enrolling by invitation	`NCT05681637` - SpO2 Difference Between Fingers of the Hand During Sequential Desaturation and Step Resaturation	N/A
Completed	`NCT05657665` - Skin Tone Measurement Method Investigation for Pulse Oximetry
Enrolling by invitation	`NCT05657288` - SpO2 Comparison Between Commercial Smartwatch and Medical-grade Pulse Oximeter During Hypoxia	N/A
Not yet recruiting	`NCT05994417` - Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants
Recruiting	`NCT05554510` - Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation
Recruiting	`NCT06063148` - Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mobile Biosensor for Measuring Vital Signs in Healthcare and Home Settings

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms